Related Experiment Video
Updated: Mar 3, 2026
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
The role of mediterranean diet and highly processed foods in inflammatory bowel diseases
D Maniero1, N Pol1, C Caranfil2
1Department of Surgery, Oncology, Gastroenterology, University of Padua, Via Giustiniani 2, 35121 Padua, Italy.
Background:
The Mediterranean Diet (MD) is considered a balanced dietary model, whereas high consumption of highly processed foods (HPF) may worsen metabolic health. We aimed to compare adherence to the MD and HPF consumption between patients with Crohn's Disease (CD) and Ulcerative Colitis (UC), and to assess their relationship with disease activity. A secondary objective was to explore the association between dietary patterns and metabolic parameters.
Methods:
Adherence to the MD was assessed using the Pyramid Mediterranean Diet Score (PyrMDS), while HPF intake was evaluated with the short questionnaire on highly processed foods (sQ-HPF).
Results:
193 consecutive IBD patients were included. CD patients showed significantly lower adherence to the MD compared with UC patients (median PyrMDS 9.3 vs 9.8, p = 0.02), while HPF consumption was similar in both groups (median sQ-HPF 3). In CD patients, a trend toward an inverse correlation was observed between MD adherence and disease activity (p = 0.07). Higher HPF consumption was positively associated with metabolic syndrome (median sQ-HPF 4 vs 3, p = 0.01).
Conclusions:
CD patients exhibit lower adherence to the MD, particularly during periods of higher disease activity, while greater HPF intake is linked to adverse metabolic profiles. Tailored nutritional counseling is important for supporting healthier dietary patterns in individuals with IBD.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...